Chang-Xiao Liu

InstitutionTianjin Institute of Pharmaceutical Research
AddressTianjin
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 1 publications in March 2020 and June 2020 and Spetember 2020 and November 2020
    All Publications
    Bar chart showing 191 publications over 18 distinct years, with a maximum of 22 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zhou Z, Wang X, Fu Y, Zhang X, Liu C. Letter to the editor: Neutralizing antibodies for the treatment of COVID-19. Acta Pharm Sin B. 2021 Jan; 11(1):304-307. PMID: 33224722.
      Citations: 4     
    2. Guo DA, Liu CX. Rudolf Bauer: China anti-COVID-19 success is closely related with the role TCM played. Chin Herb Med. 2020 Oct; 12(4):347-348. PMID: 32929323.
      Citations:    
    3. Deng JG, Hou XT, Zhang TJ, Bai G, Hao EW, Chu JJH, Wattanathorn J, Sirisa-Ard P, Soo Ee C, Low J, Liu CX. Carry forward advantages of traditional medicines in prevention and control of outbreak of COVID-19 pandemic. Chin Herb Med. 2020 Jul; 12(3):207-213. PMID: 32834811.
      Citations: 3     
    4. Liu CX. Pay attention to situation of SARS-CoV-2 and TCM advantages in treatment of novel coronavirus infection. Chin Herb Med. 2020 Apr; 12(2):97-103. PMID: 32518555.
      Citations: 5